Neuralstem Inc. (CUR) announced Tuesday that the 40 mg dose of NSI-189 showed statistically significant improvement on Cogscreen objective cognitive measures of attention and memory in its Phase 2 study.
from RTT - Before the Bell http://ift.tt/2BNCONt
via IFTTT
No comments:
Post a Comment